Eiger Biopharmaceuticals, INC.
Biopharmaceutical company
Based in CA
AI Overview
With $160K in lobbying spend across 7 quarterly filings, Eiger Biopharmaceuticals, INC is an active lobbying client. Their lobbying covers 1 issue area. Active from 2020 to 2022.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2020 | $40K |
| 2021 | $120K |
| 2022 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Eiger Biopharmaceuticals, INC. disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues
Provide strategic counsel and guidance on issues impacting rare disease treatments and pharmaceutical industry generally, and Eiger Biopharmaceuticals, Inc. specifically.
Provide strategic counsel and advocacy on issues impacting rare disease treatments and pharmaceutical industry generally, and Eiger Biopharmaceuticals, Inc. specifically.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.